From The Conversation · Ziyad Al-Aly · · 1m 30s
TL;DR: GLP-1 Drugs Carry Eye Risk Warning
FDA warns GLP-1 drugs may cause rare vision loss condition.
FDA adds NAION risk to GLP-1 drug warnings after studies show 2.6 extra cases per 100,000 users. FDA warns GLP-1 drugs may cause rare vision loss condition. The U.S. Food and Drug Administration announced on Nov. 9, 2026 that GLP-1 drugs carry a warning label for a rare eye condition that can cause vision loss.
- FDA warns GLP-1 drugs
- What is NAION?
- How the link was found
- FDA's risk analysis
Read the story version — the same reporting as a swipeable deck of 8 cards.






